Journals / Klinik Psikofarmakoloji Bülteni / 2006 / Cilt: 16 - Sayı: 4

Prodrome schizophrenia: Current developments and problems

Prodrom şizofreni, güncel gelişmeler ve sorunlar

Pages
252–262
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Considering the false positive diagnoses, there is need to discuss issues as stigmatization, pharmacological treatment to undiagnosed patients, possible stres facing the individual and his family and related ethical subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The term prodrome is used to inform that an event will happen.
📊
Key Findings & Data:Increased duration of untreated psychosis is believed to have harmful consequences.
💡
Conclusion & Impact:Considering the false positive diagnoses, there is need to discuss issues as stigmatization, pharmacological treatment to undiagnosed patients, possible stres facing the individual and his family and related ethical subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The term prodrome is used to inform that an event will happen. In prodrome schizophrenia, the person is considered to be symptomatic and will subsequently develop schizophrenia. It is clear that there is a need to diagnose schizophrenia before its onset as is the case in cancer screening. Increased duration of untreated psychosis is believed to have harmful consequences. However, there are questions regarding prodrome schizophrenia such as: do people have similar features in prodrome phase who will eventually develop schizophrenia or will everyone in prodromal phase develop schizophrenia? Some inventories were developed to screen this phase. Ultra high risk schizophrenia is formed by the most sensitive and predictive tests. Forty percent of prodrome people who share the features of the ultra high risk group are found to develop schizophrenia. Recently, the terms of vulnerability for schizophrenia, schizotaxia, schizotypy have begun to be rediscussed to simplify the identification of prodrome schizophrenia. The motivation behind the quest to identify prodrome schizophrenia diagnose is to prevent the individual from the possible toxic effects of schizophrenia to the brain, to reduce the duration of untreated psychosis and to influence the prognose positively via atypical antipsychotics with less adverse effects. Thus, early pharmacological, behavioral interventions and environmental arrangements for people in the prodrome phase are on the agenda. Considering the false positive diagnoses, there is need to discuss issues as stigmatization, pharmacological treatment to undiagnosed patients, possible stres facing the individual and his family and related ethical subjects.

Özet

Prodrom kelimesi gelişecek bir olayın habercisi anlamında kullanımaktadır. Prodrom evre şizofreni derken, kişinin belirtilerinin olduğu ve bu evreyi izleyen dönemde tam anlamıyla şizofreni gelişeceği anlatılmak istenmektedir. Kanser tarama yöntemleri gibi şizofreniyi de hastalık başlamadan tanımanın gerekliliği çok açıktır. Tedavisiz ya da müdahalesiz geçen sürenin ya da şizofren bireyin tedavisinde gecikmenin kötü sonuçları olduğuna inanılmaktadır. Ancak prodrom evreyle ilgili sorular vardır. Örneğin, her şizofreni gelişecek bireyde prodrom evre benzer midir ya da prodrom evresi sonrası her bireyde prodrom evre şizofreni mi gelişmektedir? Bu dönemi tarama amaçlı birçok ölçek geliştirilmiştir. Duyarlılığı ve öngörme gücü en yüksek olan testler aracılığıyla ultra yüksek riskli gruplar oluşturulmuştur. Ultra yüksek riskli grubun özelliklerini taşıyan bireylerin %40’ında sonradan şizofreni geliştiği saptanmıştır. Prodromal evreyi tanımayı kolaylaştırmak amacıyla şizofreniye yatkınlık, şizotipi ve şizotaksi kavramları yeniden tartışılmaya başlanmıştır. Prodrom evreyi tanımak istemenin arkasındaki bütün motivasyon, şizofreninin beyine olası toksik etkilerinden bireyi korumak, tedavisiz psikoz süresini azaltmak, çok daha az yan etkili ilaçlarla hastalığın prognozuna olumlu katkıda bulunmaktır. Bu nedenle, prodrom evrede olduğu düşünülen bireylere düşük doz antipsikotik tedavi dâhil çeşitli farmakolojik, davranışsal müdahaleler ya da çevresel düzenlemeler gündemdedir. Yanlış pozitif tanılar da düşünüldüğünde bu durum beraberinde damgalanma, hastalık tanısı almayan bireye ilaç tedavisi, aile ve bireyin yaşayabilecekleri stresi ve ilişkili etik konuları tartışmayı gerektirmektedir.

🔖

Cite This Article

EMÜL, H. M., UĞUR, M. M. (2022). Prodrome schizophrenia: Current developments and problems. Klinik Psikofarmakoloji Bülteni, Cilt: 16 - Sayı: 4, 252–262. https://ajindex.com/articles/574394

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry 1991
  2. 830 2. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD. The prodromal questionnaire (PQ): Preliminary validation of a selfreport screening measure for prodromal and psychotic syndromes. Schizophrenia Res 2005
  3. 125 3. Woods SW, Miller TJ, Davidson L, Hawkins KA, Sernyak MJ, McGlashan TH. Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients. Schizophrenia Res 2001
  4. 27 4. Malla AK., Norman RM, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Res 2002
  5. 242 5. Bottlender R, Sato T, Jager M, Wegener U, Wittmann J, Strauss A, Moller HI. The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophrenia Res 2003
  6. 44 6. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in firstepisode psychosis really matter?. Psychol Medicine 2003
  7. 110 7. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Medicine 2001
  8. 400 8. McGlashan TH. Psychosis treatment prior to psychosis onset: ethical issues. Schizophrenia Res 2001
  9. 54 9. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr Res 2001
  10. 241 10. Addington J, Van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome, Psychol Med 2004
  11. 284 11. Drake RJ, Haley G, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000
  12. 515 12. Ho B-C, Alicata D, Ward J, Moser DJ, Olegry DS, Arndt S, Andreasen NC. Untreated initial psychosis relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry 2003
  13. 148 13. Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry 2000
  14. 1828 14. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A.